PLoS ONE · 2008 · 155 citations · 14 references
MedicineNeurosciencePharmacologyBehavioral NeuroscienceNeuropharmacologyPsychopharmacologyBasal GangliaDopaminergic PharmacologyDopaminergic SignalingParkinson DiseaseReward PathwaysReward ProcessingDopaminergic NeurophysiologyDopaminergic PathwaysMesolimbic Reward PathwayPathological GamblingReward Pathway DysregulationStriatal Dopamine FunctionStriatal FunctionStriatal Physiology
The use of D2/D3 dopaminergic agonists in Parkinson's disease (PD) may lead to pathological gambling. In a placebo-controlled double-blind study in healthy volunteers, we observed riskier choices in a lottery task after administration of the D3 receptor-preferring agonist pramipexole thus mimicking risk-taking behavior in PD. Moreover, we demonstrate decreased activation in the rostral basal ganglia and midbrain, key structures of the reward system, following unexpected high gains and therefore propose that pathological gambling in PD results from the need to seek higher rewards to overcome the blunted response in this system.
14
Pathological gambling is linked to reduced activation of the mesolimbic reward system
J.H. Reuter, Thomas J. Raedler, Michael Rose et al. · Nature Neuroscience · 2005 · 741 citations
Association of Dopamine Agonist Use With Impulse Control Disorders in Parkinson Disease
Daniel Weintraub, Andrew Siderowf, Marc N. Potenza et al. · Archives of Neurology · 2006 · 664 citations · Full text
Medicine, Neurology, Psychiatry +17
Dysfunction of ventral striatal reward prediction in schizophrenia
Georg Juckel, Florian Schlagenhauf, Michael Koslowski et al. · NeuroImage · 2005 · 578 citations
Medicine, Neuroscience, Psychiatry +12